Guest Editors
Awais Ali
Abdul Wali Khan University, Department of Biochemistry
Dr. Awais Ali is a young researcher in the Department of Biochemistry at Abdul Wali Khan University Mardan (AWKUM), Pakistan. He is an expert in biochemistry and has developed a strong multidisciplinary research profile spanning immunology, virology, molecular oncology, pharmacogenomics, and computational biology. His work focuses on identifying immune-regulatory genes, structural variations, and therapeutic targets through multi-omics, machine learning, and molecular modeling approaches. He has authored impactful studies involving host-pathogen interactions, cancer immunology, vaccine design, and gene-based predictive biomarkers. As an emerging scientist, he actively contributes to collaborative research across international institutions and aims to advance precision medicine through integrative immuno-genomic strategies. His expertise aligns closely with the thematic areas of immuno-oncology, biomarker discovery, and translational genomics.
Syed Luqman Ali
Abdul Wali Khan University, Department of Biochemistry
Dr. Syed Luqman Ali is a senior researcher in the Department of Biochemistry and Bioinformatics at Abdul Wali Khan University Mardan (AWKUM), Pakistan. He has received Young Scientist and Best Research Paper awards from various ranked journals. He holds a diploma in health and advanced academic training in biochemistry, providing a strong foundation in molecular and clinical sciences. His research interests span molecular biology, immunology, infectious diseases, and biochemical pathways involved in inflammation and cancer progression. He has participated in multi-omics projects, biomarker discovery, and molecular diagnostics, contributing to interdisciplinary research initiatives aimed at understanding disease mechanisms and improving therapeutic strategies. With a growing portfolio of scientific work, he is committed to advancing translational research by integrating molecular insights with applied health sciences. His expertise aligns with immunogenomics, molecular medicine, and systems biology.
Aigul Utegenova
Astana Medical University, Department of Microbiology and Virology
Dr. Aigul Utegenova is an associate professor-researcher at the Department of Microbiology and Virology named after Sh.I. Sarabasova, Astana Medical University (Kazakhstan). She earned her PhD in Medicine in 2017, focusing on the “Immunological reactivity of the body under the influence of stress factors.” A graduate of the State Medical University of Semey (2009), she also completed a postdoctoral fellowship (2022-2024) under the Zhas Galym project on novel presymptomatic diagnostics and predictive tools for tuberculosis. Dr. Utegenova has undertaken research training at Charité, Universitätsmedizin Berlin and specialized IGRA diagnostic training in Turkey. Author of over 40 peer-reviewed publications, two monographs, and holder of two patents, her research interests include immunopathology, tuberculosis immunodiagnostics, and host immune response modulation.
Collection Overview
This collection focuses on emerging advances in immuno-oncology, emphasizing the discovery and translation of new therapeutic targets, immune biomarkers, and immunologically driven interventions for cancer treatment. With rapid progress in understanding tumor-immune interactions, immune evasion mechanisms, and the role of regulated cell death, there is an urgent need to integrate molecular insights with therapeutic innovation.
This collection welcomes high-impact original research and reviews across the following themes:
- Immune biomarkers for diagnosis, prognosis, and therapy prediction
- Immune pathway mechanisms, including checkpoint regulation, cytokine networks, and tumor microenvironment dynamics
- Novel therapeutic targets, including receptors, ligands, transcriptional regulators, and immune-modulatory genes
- Immunotherapeutic drug design, including molecular docking, structural modeling, biologics, antibodies, and small-molecule discovery
- Cancer vaccine development, such as epitope mapping, neoantigen prediction, adjuvants, and delivery systems
- Epidemiology and translational immunology, covering population-level immune trends, risk factors, and real-world immunotherapy outcomes
- Multi-omics and AI-driven immunology, integrating genomics, transcriptomics, proteomics, and computational modeling to accelerate discovery
By bringing together contributions from immunologists, oncologists, computational scientists, and drug-development researchers, this Special Issue aims to serve as a comprehensive platform advancing next-generation immunotherapies, precision cancer medicine, and innovative immune-based strategies.
